U.S. Markets closed

Ptc Therapeutics Inc (PTCT) CEO Stuart Walter Peltz Sold $3.8 million of Shares

GuruFocus.com
·1 min read

- By insider

CEO of Ptc Therapeutics Inc (30-Year Financial, Insider Trades) Stuart Walter Peltz (insider trades) sold 71,104 shares of PTCT on 10/07/2020 at an average price of $53.38 a share. The total sale was $3.8 million.


PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes. PTC Therapeutics Inc has a market cap of $3.64 billion; its shares were traded at around $53.77 with and P/S ratio of 10.62. PTC Therapeutics Inc had annual average EBITDA growth of 14.00% over the past five years. GuruFocus has detected 3 severe warning signs with PTC Therapeutics Inc. .

CEO Recent Trades:

  • CEO Stuart Walter Peltz sold 71,104 shares of PTCT stock on 10/07/2020 at the average price of $53.38. The price of the stock has increased by 0.73% since.

  • CEO Stuart Walter Peltz sold 179,811 shares of PTCT stock on 10/06/2020 at the average price of $50.09. The price of the stock has increased by 7.35% since.

Directors and Officers Recent Trades:

  • SVP, Finance & CAO Christine Marie Utter sold 3,287 shares of PTCT stock on 10/06/2020 at the average price of $49.75. The price of the stock has increased by 8.08% since.

For the complete insider trading history of PTCT, click here

.This article first appeared on GuruFocus.